Market News
Stay updated with the latest market trends, earnings, and economic indicators.
SBI Funds launches biggest IPO of 2026, price band set at ₹545-574 per share
The SBI Funds IPO will open for subscription on 14 July and close on 16 July for retail investors.
Torrent Pharma recalls select batches of Semalix injection after Dr. Reddy's notice
Torrent Pharmaceuticals is voluntarily recalling select batches of its Semalix semaglutide injection pens. This action follows a product recall notification from its manufacturer, Dr. Reddy's Laboratories. Patient safety remains of paramount importance to the company during this process. There is no risk to patients currently using this specific treatment. All other Semaglutide products sold by Torrent remain unaffected.
INR settles higher, supported by good recovery in local equities
The Indian rupee appreciated by 7 paise to settle at 95.41 (provisional) against the US dollar on Thursday even as crude oil prices firmed up and the greenback strengthened in the global markets. A recovery in the stock markets and dollar selling by state-run lenders supported the local currency amid rising volatility triggered by the fresh escalation in the West Asia crisis. At the interbank foreign exchange market, the rupee opened lower by 4 paise at 95.52 against the US dollar and later traded in the range of 95.58 to 95.28 during the day. It settled at 95.41 (provisional), up 7 paise from the previous close. The rupee had declined by 52 paise to settle at 95.48 against the US dollar on Wednesday. Indian shares ended modestly higher on Thursday, after having fallen heavily in the previous session amid escalating hostilities in the Middle East. At the close of the market, the NSE Nifty 50 advanced 80.75 points (0.34%) to settle at 23,962.80, while the BSE Sensex gained 238.22 ...
SBI Funds IPO: Holding State Bank Of India Shares? Here Is How To Claim Your Special Quota
Unlike some public issues that offer a concession to retail investors, SBI shareholders will not receive any discount on the issue price.
Planning To Move To US? Stricter H-1B, Green Card Rules Kick In This August — Check Details
Trump's proposed H-1B visa changes could tighten rules for Indian professionals and students.
Phoenix Mills’ growth hinges on more than retail consumption
Phoenix Mills' stock rose 5% after retail consumption beat estimates for a third straight quarter, but rental income continues to lag because most contracts are fixed and high-growth categories carry low revenue shares.
Gold, silver prices decline in India: What's next for bullion
Gold, silver prices drop on MCX as strong US dollar, higher interest rate expectations, and West Asia tensions impact global bullion markets.
AstraZeneca shares slide after Ionis-partnered drug fails late-stage heart disease trial
AstraZeneca shares fell after Wainua failed a key trial. The drug did not reduce cardiovascular deaths or heart problems. Wainua showed no effect in patients already on stabilizer therapy. A subgroup taking the drug without stabilizers showed a nominal benefit. This setback impacts a projected two billion dollar sales opportunity.
Indian Retail Participation Rises with 1.3 Million New Active Investors Joining Exchanges - Sahi
Indian Retail Participation Rises with 1.3 Million New Active Investors Joining ExchangesSahi
TCS Q1 Results Live Updates: Stock recovering from day's low ahead of earnings
TCS Q1 Results Live Updates: Tata Group giant and India's largest IT services company, Tata Consultancy Services Ltd. (TCS) is set to report its results after market hours on Thursday, July 9. As per a CNBC-TV18 poll, the company's US Dollar revenue is seen flat at $7,611 million, compared to $7,621 million in the March quarter. The stock has declined 35% so far this year and is now trading at 14 times its financial year 2028 estimated price-to-earnings, well below its historical averages. Watch this space for all the LIVE earnings updates from TCS.
Phoenix Mills shares rise after strong Q1; JPMorgan highlights why downside risk is limited
Phoenix Mills shares rose 3.4% after strong Q1 FY27 growth, driven by retail consumption, commercial office, and hospitality. JP Morgan gave an overweight rating.
Godrej Consumer shares climb 2% as ICICI Securities upgrades the stock to a buy, raises target price
ICICI Securities upgraded Godrej Consumer Products to 'buy', raising the target price to ₹1,300. With expectations for double-digit growth and a recovery in key markets, investor interest surges.